Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mende

Showing results (1421-1430 of 1,567) with videos related to

Pageof 157
Sort By:
Cell Stem Cell|July 16, 2019
GPD1 Specifically Marks Dormant Glioma Stem Cells with a Distinct Metabolic ProfilePatricia Rusu, Chunxuan Shao, Anna Neuerburg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 12, 2021
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccine-Breakthrough Infection Phenotype Includes Significant Symptoms, Live Virus Shedding, and Viral Genetic DiversitySimon D Pollett, Stephanie A Richard, Anthony C Fries, et al.
Neuro-Oncology|August 22, 2020
Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastomaJonas Ecker, Venu Thatikonda, Gianluca Sigismondo, et al.
Oncotarget|February 20, 2016
Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO gradeMelissa Schmidt, Andreas Mock, Christine Jungk, et al.
Acta Neuropathologica|October 25, 2013
Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous systemChristian Koelsche, Felix Sahm, David Capper, et al.
Neuro-Oncology|October 31, 2019
Metabolic reprogramming associated with aggressiveness occurs in the G-CIMP-high molecular subtypes of IDH1mut lower grade gliomasVictor Ruiz-Rodado, Tathiane M Malta, Tomohiro Seki, et al.
Cancer Cell|March 26, 2019
Evolutionary Trajectories of IDH<sup>WT</sup> Glioblastomas Reveal a Common Path of Early Tumorigenesis Instigated Years ahead of Initial DiagnosisVerena Körber, Jing Yang, Pankaj Barah, et al.
Nature Medicine|September 5, 2025
Molecularly matched targeted therapies plus radiotherapy in glioblastoma: the phase 1/2a N<sup>2</sup>M<sup>2</sup> umbrella trialWolfgang Wick, Lisa-Marie Lanz, Antje Wick, et al.
Nature Communications|March 7, 2024
Disentangling top-down drivers of mortality underlying diel population dynamics of Prochlorococcus in the North Pacific Subtropical GyreStephen J Beckett, David Demory, Ashley R Coenen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in MeningiomasCarmen Rapp, Steffen Dettling, Fang Liu, et al.
Pageof 157

Showing results (1421-1430 of 1,567) with videos related to

Sort By:
Pageof 157
Cell Stem Cell|July 16, 2019
GPD1 Specifically Marks Dormant Glioma Stem Cells with a Distinct Metabolic ProfilePatricia Rusu, Chunxuan Shao, Anna Neuerburg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 12, 2021
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccine-Breakthrough Infection Phenotype Includes Significant Symptoms, Live Virus Shedding, and Viral Genetic DiversitySimon D Pollett, Stephanie A Richard, Anthony C Fries, et al.
Neuro-Oncology|August 22, 2020
Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastomaJonas Ecker, Venu Thatikonda, Gianluca Sigismondo, et al.
Oncotarget|February 20, 2016
Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO gradeMelissa Schmidt, Andreas Mock, Christine Jungk, et al.
Acta Neuropathologica|October 25, 2013
Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous systemChristian Koelsche, Felix Sahm, David Capper, et al.
Neuro-Oncology|October 31, 2019
Metabolic reprogramming associated with aggressiveness occurs in the G-CIMP-high molecular subtypes of IDH1mut lower grade gliomasVictor Ruiz-Rodado, Tathiane M Malta, Tomohiro Seki, et al.
Cancer Cell|March 26, 2019
Evolutionary Trajectories of IDH<sup>WT</sup> Glioblastomas Reveal a Common Path of Early Tumorigenesis Instigated Years ahead of Initial DiagnosisVerena Körber, Jing Yang, Pankaj Barah, et al.
Nature Medicine|September 5, 2025
Molecularly matched targeted therapies plus radiotherapy in glioblastoma: the phase 1/2a N<sup>2</sup>M<sup>2</sup> umbrella trialWolfgang Wick, Lisa-Marie Lanz, Antje Wick, et al.
Nature Communications|March 7, 2024
Disentangling top-down drivers of mortality underlying diel population dynamics of Prochlorococcus in the North Pacific Subtropical GyreStephen J Beckett, David Demory, Ashley R Coenen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in MeningiomasCarmen Rapp, Steffen Dettling, Fang Liu, et al.
Pageof 157